Logo image of CAVA

CAVA GROUP INC (CAVA) Stock Fundamental Analysis

NYSE:CAVA - New York Stock Exchange, Inc. - US1489291021 - Common Stock - Currency: USD

92.05  +0.6 (+0.66%)

After market: 91.77 -0.28 (-0.3%)

Fundamental Rating

5

CAVA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 133 industry peers in the Hotels, Restaurants & Leisure industry. While CAVA has a great health rating, there are worries on its profitability. CAVA shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CAVA was profitable.
In the past year CAVA had a positive cash flow from operations.
CAVA Yearly Net Income VS EBIT VS OCF VS FCFCAVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

The Return On Assets of CAVA (11.56%) is better than 87.97% of its industry peers.
CAVA has a better Return On Equity (19.56%) than 77.44% of its industry peers.
CAVA's Return On Invested Capital of 3.99% is in line compared to the rest of the industry. CAVA outperforms 41.35% of its industry peers.
Industry RankSector Rank
ROA 11.56%
ROE 19.56%
ROIC 3.99%
ROA(3y)0.8%
ROA(5y)N/A
ROE(3y)-2.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CAVA Yearly ROA, ROE, ROICCAVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

CAVA has a better Profit Margin (13.70%) than 85.71% of its industry peers.
CAVA has a worse Operating Margin (5.34%) than 62.41% of its industry peers.
CAVA has a worse Gross Margin (32.26%) than 72.93% of its industry peers.
CAVA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.34%
PM (TTM) 13.7%
GM 32.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.15%
GM growth 5YN/A
CAVA Yearly Profit, Operating, Gross MarginsCAVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CAVA is destroying value.
The number of shares outstanding for CAVA has been increased compared to 1 year ago.
CAVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CAVA Yearly Shares OutstandingCAVA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
CAVA Yearly Total Debt VS Total AssetsCAVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 13.56 indicates that CAVA is not in any danger for bankruptcy at the moment.
CAVA has a better Altman-Z score (13.56) than 99.25% of its industry peers.
CAVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 13.56
ROIC/WACC0.44
WACC9.06%
CAVA Yearly LT Debt VS Equity VS FCFCAVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

CAVA has a Current Ratio of 3.00. This indicates that CAVA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.00, CAVA belongs to the top of the industry, outperforming 93.23% of the companies in the same industry.
A Quick Ratio of 2.95 indicates that CAVA has no problem at all paying its short term obligations.
CAVA's Quick ratio of 2.95 is amongst the best of the industry. CAVA outperforms 93.98% of its industry peers.
Industry RankSector Rank
Current Ratio 3
Quick Ratio 2.95
CAVA Yearly Current Assets VS Current LiabilitesCAVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.90% over the past year.
CAVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.11%.
The Revenue has been growing by 24.44% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)43.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
Revenue 1Y (TTM)32.11%
Revenue growth 3Y24.44%
Revenue growth 5YN/A
Sales Q2Q%28.12%

3.2 Future

CAVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.81% yearly.
CAVA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.33% yearly.
EPS Next Y19.58%
EPS Next 2Y20.47%
EPS Next 3Y26.76%
EPS Next 5Y30.81%
Revenue Next Year24.1%
Revenue Next 2Y22.81%
Revenue Next 3Y22.57%
Revenue Next 5Y20.33%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CAVA Yearly Revenue VS EstimatesCAVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
CAVA Yearly EPS VS EstimatesCAVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 156.02, which means the current valuation is very expensive for CAVA.
Based on the Price/Earnings ratio, CAVA is valued a bit more expensive than 63.91% of the companies in the same industry.
CAVA is valuated expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
CAVA is valuated quite expensively with a Price/Forward Earnings ratio of 129.43.
Based on the Price/Forward Earnings ratio, CAVA is valued a bit more expensive than 68.42% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CAVA to the average of the S&P500 Index (21.76), we can say CAVA is valued expensively.
Industry RankSector Rank
PE 156.02
Fwd PE 129.43
CAVA Price Earnings VS Forward Price EarningsCAVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

79.70% of the companies in the same industry are cheaper than CAVA, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CAVA is valued a bit more expensive than the industry average as 60.90% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 209.17
EV/EBITDA 85
CAVA Per share dataCAVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CAVA's earnings are expected to grow with 26.76% in the coming years.
PEG (NY)7.97
PEG (5Y)N/A
EPS Next 2Y20.47%
EPS Next 3Y26.76%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CAVA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAVA GROUP INC

NYSE:CAVA (7/11/2025, 8:04:00 PM)

After market: 91.77 -0.28 (-0.3%)

92.05

+0.6 (+0.66%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-20 2025-08-20/amc
Inst Owners79.31%
Inst Owner Change0%
Ins Owners5.67%
Ins Owner Change-0.07%
Market Cap10.65B
Analysts82.5
Price Target115.12 (25.06%)
Short Float %10.04%
Short Ratio3.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.3%
Min EPS beat(2)-24.49%
Max EPS beat(2)55.09%
EPS beat(4)3
Avg EPS beat(4)24.19%
Min EPS beat(4)-24.49%
Max EPS beat(4)55.09%
EPS beat(8)7
Avg EPS beat(8)365.12%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.44%
Max Revenue beat(2)-0.42%
Revenue beat(4)2
Avg Revenue beat(4)1.44%
Min Revenue beat(4)-0.44%
Max Revenue beat(4)4.29%
Revenue beat(8)5
Avg Revenue beat(8)1.61%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.66%
PT rev (3m)-8.61%
EPS NQ rev (1m)0.23%
EPS NQ rev (3m)-17%
EPS NY rev (1m)4.9%
EPS NY rev (3m)7.82%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)0.58%
Valuation
Industry RankSector Rank
PE 156.02
Fwd PE 129.43
P/S 10.27
P/FCF 209.17
P/OCF 66.04
P/B 14.66
P/tB 14.73
EV/EBITDA 85
EPS(TTM)0.59
EY0.64%
EPS(NY)0.71
Fwd EY0.77%
FCF(TTM)0.44
FCFY0.48%
OCF(TTM)1.39
OCFY1.51%
SpS8.96
BVpS6.28
TBVpS6.25
PEG (NY)7.97
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.56%
ROE 19.56%
ROCE 5.05%
ROIC 3.99%
ROICexc 6.03%
ROICexgc 6.06%
OM 5.34%
PM (TTM) 13.7%
GM 32.26%
FCFM 4.91%
ROA(3y)0.8%
ROA(5y)N/A
ROE(3y)-2.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.15%
GM growth 5YN/A
F-Score6
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 172.8%
Cap/Sales 10.64%
Interest Coverage 250
Cash Conversion 135.31%
Profit Quality 35.84%
Current Ratio 3
Quick Ratio 2.95
Altman-Z 13.56
F-Score6
WACC9.06%
ROIC/WACC0.44
Cap/Depr(3y)238.66%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.25%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
EPS Next Y19.58%
EPS Next 2Y20.47%
EPS Next 3Y26.76%
EPS Next 5Y30.81%
Revenue 1Y (TTM)32.11%
Revenue growth 3Y24.44%
Revenue growth 5YN/A
Sales Q2Q%28.12%
Revenue Next Year24.1%
Revenue Next 2Y22.81%
Revenue Next 3Y22.57%
Revenue Next 5Y20.33%
EBIT growth 1Y131.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year250.03%
EBIT Next 3Y78.97%
EBIT Next 5Y53.2%
FCF growth 1Y158.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y373.06%
OCF growth 3Y262.05%
OCF growth 5YN/A